Skip to main content

Rural Health
Funding by Topic: HIV and AIDS

Summaries of funding programs are provided by RHIhub for your convenience. Please contact the funder directly for the most complete and current information.

Gilead COMPASS Initiative Transformative Grants
Grants for organizations working in the southern United States to build the capacity to provide and sustain high quality and accessible HIV education and care.
Geographic coverage: The service area is 12 southern states including Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, and Texas.
Application Deadline: May 17, 2021
Sponsors: Emory University, Gilead COMPASS Initiative
Samara Fund Grants
Funding for projects and organizations that serve the LGBTQ community or support HIV/AIDS services or prevention at the grassroots level in Vermont. A priority area includes rural and underserved areas of the state.
Geographic coverage: Vermont
Application Deadline: May 28, 2021
Sponsor: Vermont Community Foundation
Ryan White HIV/AIDS Program Part C Early Intervention Services Program: Existing Geographic Service Areas
Funding to provide comprehensive primary healthcare and support services in an outpatient setting for low income, uninsured, and underserved people with HIV.
Geographic coverage: Nationwide
Application Deadline: Jun 21, 2021
Sponsors: Health Resources and Services Administration, HRSA HIV/AIDS Bureau, U.S. Department of Health and Human Services
Native American Research Centers for Health (NARCH) (S06)
Offers grants for new or continued Native American Research Centers for Health, which support research and research training to meet the health needs of American Indian/Alaska Native (AI/AN) communities.
Geographic coverage: Nationwide
Application Deadline: Jun 24, 2021
Sponsors: Indian Health Service, National Institute on Minority Health and Health Disparities, National Institutes of Health, U.S. Department of Health and Human Services
Housing Opportunities for Persons With AIDS Competitive Grant: Housing as an Intervention to Fight AIDS
Funding to create and implement new projects that align with initiatives aimed at ending the HIV/AIDS epidemic using housing as an intervention in ending the epidemic. HUD is looking to fund innovative projects including community-level coordination, data collection with emphasis on stable housing and positive health outcomes, culturally competent approaches to providing housing and services, and a systemic approach to advance equity in underserved communities that can serve as a national place-based model.
Geographic coverage: Nationwide
Application Deadline: Jul 6, 2021
Sponsor: U.S. Department of Housing and Urban Development
Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)
Grants for observational research to understand the role of structural racism and discrimination in causing and sustaining health disparities and intervention research that addresses structural racism and discrimination to improve minority health and reduce health disparities.
Geographic coverage: Nationwide and U.S. Territories
Letter of Intent (Optional): Jul 20, 2021
Application Deadline: Aug 24, 2021
Sponsors: National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Environmental Health Sciences, National Institute of Mental Health, National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, National Institute on Minority Health and Health Disparities, National Institutes of Health, U.S. Department of Health and Human Services
HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional)
Funding for NIH high priority research relevant to drug misuse and HIV/AIDS. Research priorities revolve around the National Institute on Drug Abuse's Seek, Test, Treat, and Retain framework, and include reducing health disparities in the incidence of new HIV infections or in treatment outcomes of those living with HIV/AIDS. Populations of interest include urban, suburban, and rural drug users; populations at elevated risk for HIV, such as men who have sex with men; and people in rural areas who use opioids and injection drugs.
Geographic coverage: Nationwide and U.S. territories
Application Deadline: Sep 8, 2021
Sponsors: National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services
Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Optional)
Grants for projects designed to improve understanding of viral suppression and HIV transmission in the U.S. using population-level epidemiology, tools from data science approaches, and implementation science research.
Geographic coverage: Nationwide and U.S. territories
Application Deadline: Sep 8, 2022
Sponsors: National Institutes of Health, U.S. Department of Health and Human Services
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 and R34 Clinical Trial Optional)
Grants for research projects that develop or test innovative models of care which integrate HIV, substance use disorder (SUD) prevention and treatment with primary care services. Research in states and counties identified in the federal Ending the HIV Epidemic Initiative, including areas with the highest rural HIV burden, are specifically encouraged.
Geographic coverage: Nationwide
Application Deadline: Aug 11, 2023
Sponsors: National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services
Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders
Notice of Special Interest for research to explore and develop telehealth methods and strategies for diagnosis, prevention, treatment, and population analysis in individuals living with HIV and substance use disorder.
Geographic coverage: Nationwide and U.S. Territories
Application Deadline: Sep 7, 2024
Sponsors: National Institute on Drug Abuse, National Institutes of Health